In a recent congressional trade report, it was revealed that Stephen Lynch, a member of Congress from Massachusetts’s 8th congressional district (MA08), has made significant changes to his investment portfolio. Lynch has sold assets from a variety of mutual funds and redirected the proceeds into the Vanguard Target (NYSE:) Date 2025 Mutual Fund.
The report details that Lynch sold assets from American Funds Euro-Pacific Mutual Fund, American Funds Income Fund of America, Federated Kaufman Small Cap A Mutual Fund, Fidelity Balanced Fund, Fidelity Contra Fund Mutual Fund, and Fidelity Emerging Markets Mutual Fund. The value of these sales ranged from $1,001 to $250,000.
The most noteworthy sale was from the Fidelity Contra Fund Mutual Fund, with the transaction amounting to somewhere between $100,001 and $250,000. All these assets were held in Lynch’s South Boston Community Health (NYSE:) Center 403(b) account.
Simultaneously, Lynch made a significant purchase in the Vanguard Target Date 2025 Mutual Fund. The transaction was valued between $250,001 and $500,000. The report explicitly states that the proceeds from the sale of the other mutual funds were invested in the Vanguard fund.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.